Angiotensin as a target for the treatment of Alzheimer’s disease, anxiety and depression

By Gard Paul R  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 1, 2004-02 ,pp. : 7-14

Informa Healthcare

Access to resources Recommend Favorite

Drug Interactions with Angiotensin Receptor Blockers: A Comparison with Other Antihypertensives

By Unger T.   Kaschina E.  

Drug Safety, Vol. 26, Iss. 10, 2003-01 ,pp. : 707-720

Adis International

Access to resources Recommend Favorite

Current status of renin–aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease

By Ashby Emma Louise   Kehoe Patrick G  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 10, 2013-10 ,pp. : 1229-1242

Informa Healthcare

Access to resources Recommend Favorite

The Role of Glucose in the Pathogenesis of Alzheimer's Disease Revisited:What Does it Tell us About the Therapeutic use of Lithium?

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-01 ,pp. : 175-192

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?

By Irwin Nigel   Gault Victor   Flatt Peter R  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 9, 2010-09 ,pp. : 1039-1048

Informa Healthcare

Access to resources Recommend Favorite